121例尿路上皮癌合并其他多器官原发癌的临床病理特征及预后

目的 探讨尿路上皮癌(UC)合并其他多器官原发癌( MPC)的临床病理特征和预后.方法 2010年1月1日至2018年5月1日在北京大学第三医院诊治的UC合并MPC患者121例,通过查阅电子病例系统和电话随访,回顾性分析患者的流行病学特征、临床病理特征和预后.结果 合并MPC的UC患者占全部UC患者的9.74%(121/1 242),男女比例为2.10 ∶ 1,在上尿路MPC亚组中男女比例为1 ∶ 1. MPC患者更常见于老年人,中位年龄为68岁.合并肿瘤共131例次,常累及器官依次为消化系统[ 41.98%( 55/131)]、泌尿及男性生殖系统[ 20.61%( 27/131)]和女性生殖...

Full description

Saved in:
Bibliographic Details
Published in中华肿瘤杂志 Vol. 41; no. 10; pp. 760 - 764
Main Authors 顾阳春, 叶剑飞, 曹宝山, 王墨培, 马潞林, 马力文
Format Journal Article
LanguageChinese
Published 北京大学第三医院肿瘤化疗与放射病科100191%北京大学第三医院泌尿外科100191 01.10.2019
Subjects
Online AccessGet full text
ISSN0253-3766
DOI10.3760/cma.j.issn.0253-3766.2019.10.007

Cover

Abstract 目的 探讨尿路上皮癌(UC)合并其他多器官原发癌( MPC)的临床病理特征和预后.方法 2010年1月1日至2018年5月1日在北京大学第三医院诊治的UC合并MPC患者121例,通过查阅电子病例系统和电话随访,回顾性分析患者的流行病学特征、临床病理特征和预后.结果 合并MPC的UC患者占全部UC患者的9.74%(121/1 242),男女比例为2.10 ∶ 1,在上尿路MPC亚组中男女比例为1 ∶ 1. MPC患者更常见于老年人,中位年龄为68岁.合并肿瘤共131例次,常累及器官依次为消化系统[ 41.98%( 55/131)]、泌尿及男性生殖系统[ 20.61%( 27/131)]和女性生殖系统[12.21%(16/131)].上尿路MPC中,累及消化系统肿瘤比例最高[47.37%(9/19)];但在同时性MPC组中,累及泌尿及男性生殖系统肿瘤比例最高[占37.14%(13/35)].部分患者确诊UC前有放化疗史,确诊Lynch综合征2例.合并MPC的UC患者中位生存时间( mOS)为132个月,其中首发UC患者(包括异时性MPC中首发UC和同时性MPC)的mOS 为120个月.同时性MPC组患者的mOS为84个月,短于异时性MPC组(178个月, P<0.001).结论 UC合并MPC发生率较高,合并消化系统和生殖系统最常见.对于确诊UC的患者,特别是有肿瘤既往史或家族史者以及老年患者,筛查MPC有助于患者的早诊早治和改善预后.
AbstractList 目的 探讨尿路上皮癌(UC)合并其他多器官原发癌( MPC)的临床病理特征和预后.方法 2010年1月1日至2018年5月1日在北京大学第三医院诊治的UC合并MPC患者121例,通过查阅电子病例系统和电话随访,回顾性分析患者的流行病学特征、临床病理特征和预后.结果 合并MPC的UC患者占全部UC患者的9.74%(121/1 242),男女比例为2.10 ∶ 1,在上尿路MPC亚组中男女比例为1 ∶ 1. MPC患者更常见于老年人,中位年龄为68岁.合并肿瘤共131例次,常累及器官依次为消化系统[ 41.98%( 55/131)]、泌尿及男性生殖系统[ 20.61%( 27/131)]和女性生殖系统[12.21%(16/131)].上尿路MPC中,累及消化系统肿瘤比例最高[47.37%(9/19)];但在同时性MPC组中,累及泌尿及男性生殖系统肿瘤比例最高[占37.14%(13/35)].部分患者确诊UC前有放化疗史,确诊Lynch综合征2例.合并MPC的UC患者中位生存时间( mOS)为132个月,其中首发UC患者(包括异时性MPC中首发UC和同时性MPC)的mOS 为120个月.同时性MPC组患者的mOS为84个月,短于异时性MPC组(178个月, P<0.001).结论 UC合并MPC发生率较高,合并消化系统和生殖系统最常见.对于确诊UC的患者,特别是有肿瘤既往史或家族史者以及老年患者,筛查MPC有助于患者的早诊早治和改善预后.
Abstract_FL Objective To investigate the incidence and clinical characteristics of urothelial carcinoma (UC) accompanied with multiple primary carcinoma (MPC). Methods The clinical data of 121 UC patients with MPC in Peking University Third Hospital from January 2010 to May 2018 were retrospectly analyzed. Results UC patients with MPC accounted for 9.74%( 121/1 242) of all the UC patients. The ratio of male to female patients was 2.10 ∶ 1 in the total MPC patients, but it was 1 ∶ 1 in the upper urinary tract MPC subgroup. The MPC patients were more common in elderly people, whose medium age was 68 (32?93) years old. Of all the location (131 person?time) of other tumors besides UC, the digestive system tumors occurred most frequently, accounting for 41.98%( 55/131), followed by the urinary and male reproductive system tumors (20.61%, 27/131) and the female reproductive system ( 12.21%, 16/131). The proportion of the digestive system tumors (47.37%, 9/19) was the highest in the upper urinary tract MPC, with a total number of the other primary cancer of 19 person?time. However, the proportion of the urinary and male reproductive system tumors (37.14%, 13/35) was higher in the synchronous MPC group, with a total number of the other primary cancer of 35 person?time.Some patients had a history of radiotherapy and/or chemotherapy before UC was diagnosed. We also observed 2 cases of genetically confirmed Lynch syndrome. The median overall survival (mOS) of UC patients with MPC was 132 months, and the mOS of patients with UC as the first malignancy ( including synchronous MPC and UC as the first malignancy in metachronous MPC) was 120 months. The mOS of the synchronous MPC group was 84 months, which was significantly shorter than 178 months of metachronous MPC group (χ2=14.029, P<0.001). Conclusions The incidence of UC accompanied with MPC is not low, and the most common sites of MPC are the digestive system and reproductive system. Therefore, screening for MPC in UC patients, especially those with personal or family history of tumors, as well as elderly patients, may help early diagnosis and treatment of MPC patients and improve their prognoses.
Author 王墨培
曹宝山
马潞林
叶剑飞
马力文
顾阳春
AuthorAffiliation 北京大学第三医院肿瘤化疗与放射病科100191%北京大学第三医院泌尿外科100191
AuthorAffiliation_xml – name: 北京大学第三医院肿瘤化疗与放射病科100191%北京大学第三医院泌尿外科100191
Author_FL Cao Baoshan
Ye Jianfei
Gu Yangchun
Ma Lulin
Ma Liwen
Wang Mopei
Author_FL_xml – sequence: 1
  fullname: Gu Yangchun
– sequence: 2
  fullname: Ye Jianfei
– sequence: 3
  fullname: Cao Baoshan
– sequence: 4
  fullname: Wang Mopei
– sequence: 5
  fullname: Ma Lulin
– sequence: 6
  fullname: Ma Liwen
Author_xml – sequence: 1
  fullname: 顾阳春
– sequence: 2
  fullname: 叶剑飞
– sequence: 3
  fullname: 曹宝山
– sequence: 4
  fullname: 王墨培
– sequence: 5
  fullname: 马潞林
– sequence: 6
  fullname: 马力文
BookMark eNo9kM9Kw0AYxPdQwVr7GIKXxG-z2d3kKMV_UBBBzyXZJNpSUzCI0JvQirbSxovaXgTx4Kl6kNoq1JfJR_QtjCieBn4zzMAskFzYCH1ClinoTApYUYeOXtOrURTqYHCmZVDoBlBbzxIAMkfy_3yeFKOo6gK3uDRtKvNkhxo0mXXx-ePz9SmZdNLhKB1cYnyO0zG2x8n7NT4McfCIo1vs3WH_KnPTYSuZvOBbJ71pp_FZejHF2Sn2O1_3LYx7i2QucOqRX_zTAtlbX9stbWrl7Y2t0mpZiygAaNLglnJtm1nKD1whA-Eoy6SuCrj0QAYW8xwhTakyxD0mfFeawMHwmS08cBUrkKXf3hMnDJxwv1JrHB-F2WKledCs_xyQ7VBg304lcZY
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0253-3766.2019.10.007
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Clinical analysis of 121 cases of urothelial carcinoma accompanied with multiple primary carcinoma
EndPage 764
ExternalDocumentID zhzl201910010
GroupedDBID ---
-05
123
2B.
4A8
92F
92I
93N
ABDBF
ABJNI
ACGFS
ACUHS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CW9
EOJEC
OBODZ
PSX
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1000-7258cb9938cefb67f6ac841bcf57d07f83da6747c1bc5d36eb740502e396d0bc3
ISSN 0253-3766
IngestDate Thu May 29 04:00:02 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 10
Keywords 尿路上皮肿瘤
临床特征
Urothelial neoplasms
Prognosis
流行病学
预后
Clinical characteristics
Neoplasms,Multiple primary
Epidemiology
肿瘤,多原发
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1000-7258cb9938cefb67f6ac841bcf57d07f83da6747c1bc5d36eb740502e396d0bc3
PageCount 5
ParticipantIDs wanfang_journals_zhzl201910010
PublicationCentury 2000
PublicationDate 2019-10-01
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: 2019-10-01
  day: 01
PublicationDecade 2010
PublicationTitle 中华肿瘤杂志
PublicationTitle_FL Chinese Journal of Oncology
PublicationYear 2019
Publisher 北京大学第三医院肿瘤化疗与放射病科100191%北京大学第三医院泌尿外科100191
Publisher_xml – name: 北京大学第三医院肿瘤化疗与放射病科100191%北京大学第三医院泌尿外科100191
SSID ssib058574917
ssib051368316
ssib007279245
ssib000995398
ssj0042033
ssib006576341
ssib001103529
Score 2.263112
Snippet 目的 探讨尿路上皮癌(UC)合并其他多器官原发癌( MPC)的临床病理特征和预后.方法 2010年1月1日至2018年5月1日在北京大学第三医院诊治的UC合并MPC患者121例,通过查阅电子病...
SourceID wanfang
SourceType Aggregation Database
StartPage 760
Title 121例尿路上皮癌合并其他多器官原发癌的临床病理特征及预后
URI https://d.wanfangdata.com.cn/periodical/zhzl201910010
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate
  issn: 0253-3766
  databaseCode: ABDBF
  dateStart: 20150223
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssj0042033
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Na9RANNQtiBdRVPwsPTjgZdd8zOcx2c1SBAWhhd7qZppYRFew7WVvQitapa0Xtb0I4sFT9SC1Vah_ZsPqv_C9yXQTS6EqXsLbyft-k3nzkplZx7mqXZVpL0vrLIEwQMZ364mmuu77KfOp5lpz3OB88xafmKI3ptn0SO1OZdXS4kLS0L1D95X8S1ShDeKKu2T_IrJDptAAMMQXrhBhuP5RjD3fIzElUUxkRGJGIpdEbRJLEgkSts0tSWRIYkFUSMLYAIrIJiIrl0hpqBSJOAKSGQCoIqJMS0iREJEVCQ0yMFEGkAC0DdAmyqtwNrIktdIjakSE-2oIlIIASOcISIUKIA5Y4VmGiAwSfcOnUDWuTqMt87Bl8FuoDFgtfWO-QA1B85gT1cJGZA5KDjOu4e2hQAAANwoMLhCxEsXoYf2ijIVAFBAVlyhAE1nl0S1GmQj4eiWKQNWK4IA1hQvBbZGqvm3x1HDdXvF8GKFNdBbaCZFr2mCEwgAtEhrfQTveKsKsLBUED80y7jvEKQVnQw5XK0IaD8JP05mKnoSurwQMRCs8-A8qb-Kz_6chR_cXPdJ236Lb8QNCKxnLZwFmLF5Nr9SrDiNuJVmK4p8k7LxLFKfZH0zpuGgLnkP9oNO4Z6Q0hlJwYaZqmLWZopzODBeZ9uZ69xEDtXSPOaM-kPg1ZzSMWlG7UmIoVj0CE4yCmqSc4nMoyINKySDwxM3ySzzzAi6DssSC6ltQ8wqkmA1S3w3MKpd9pY8716xV14-yyewj7Gad7t3KlHfylHPS1qrjYTHwnHZGenNnnNsw6PT3nuefvv_48rG_szLY3BpsvMjXn-a72_nydv_bq_z9Zr7xId96k6--zddewt3B5lJ_53P-dWXwenmw_mTwbDffe5yvrfx8t5Svr551ptrxZHOibv-XpT6PXwPrwmdSJ1DYSJ1mCRcZ72hJvURnTMy6IpPBbIcLKjQ0sdmAp4mAstD100DxWTfRwTmn1n3YTc874x2ZMJoK4WVcUy8VkulUpbQDhZjfcTN2wRmzLpix4-78zG9xvXgUwiXnRPkcX3ZqC48W0ytQRywkY7Yr_AI2vdJj
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=121%E4%BE%8B%E5%B0%BF%E8%B7%AF%E4%B8%8A%E7%9A%AE%E7%99%8C%E5%90%88%E5%B9%B6%E5%85%B6%E4%BB%96%E5%A4%9A%E5%99%A8%E5%AE%98%E5%8E%9F%E5%8F%91%E7%99%8C%E7%9A%84%E4%B8%B4%E5%BA%8A%E7%97%85%E7%90%86%E7%89%B9%E5%BE%81%E5%8F%8A%E9%A2%84%E5%90%8E&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%82%BF%E7%98%A4%E6%9D%82%E5%BF%97&rft.au=%E9%A1%BE%E9%98%B3%E6%98%A5&rft.au=%E5%8F%B6%E5%89%91%E9%A3%9E&rft.au=%E6%9B%B9%E5%AE%9D%E5%B1%B1&rft.au=%E7%8E%8B%E5%A2%A8%E5%9F%B9&rft.date=2019-10-01&rft.pub=%E5%8C%97%E4%BA%AC%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%B8%89%E5%8C%BB%E9%99%A2%E8%82%BF%E7%98%A4%E5%8C%96%E7%96%97%E4%B8%8E%E6%94%BE%E5%B0%84%E7%97%85%E7%A7%91100191%25%E5%8C%97%E4%BA%AC%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%B8%89%E5%8C%BB%E9%99%A2%E6%B3%8C%E5%B0%BF%E5%A4%96%E7%A7%91100191&rft.issn=0253-3766&rft.volume=41&rft.issue=10&rft.spage=760&rft.epage=764&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-3766.2019.10.007&rft.externalDocID=zhzl201910010
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhzl%2Fzhzl.jpg